To elucidate pathology of autoimmune disease and develop new treatment

To elucidate pathology of autoimmune disease and develop new treatment - Development of new treatment in autoimmun diseases

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000017559

Enrollment

200

Registered

2015-05-14

Start date

2010-09-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

autoimmune diseases

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients who are suffring from RA,SLE,pSS, SS, PM/DM. MCTD, MG, MS

Exclusion criteria

Exclusion criteria: Patients who thier physicians consider as not appropriate

Design outcomes

Primary

Measure	Time frame
Efficacy at following visits	—

Countries

Japan

Contacts

Public ContactYuko Kaneko

Keio University School of Medicine Division of Rheumatology, Department of Internal Medicine

ykaneko@z6.keio.jp03-3353-1211

Outcome results